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Abstract
Background: Potential functional allele T/C single nucleotide polymorphism (SNP) of Interleukin 10 (IL-10)
promoter -819 (rs1800871) has been implicated in gastric cancer risk. We aimed to explore the role of T/C SNP of
IL-10 -819 in the susceptibility to gastric cancer through a systematic review and meta-analysis.
Methods: Each initially included article was scored for quality appraisal. Desirable data were extracted and
registered into databases. 11 studies were ultimately eligible for the meta-analysis of IL-10 -819 T/C SNP. We
adopted the most probably appropriate genetic model (recessive model). Potential sources of heterogeneity were
sought out via subgroup and sensitivity analyses, and publication biases were estimated.
Results: IL-10 -819 TT genotype is associated with the overall reduced gastric cancer risk among Asians and even
apparently observed among high quality subgroup Asians. IL-10-819 TT genotype is not statistically associated with
the overall reduced gastric cancer susceptibility in persons with H. pylori infection compared with controls without
H. pylori infection. IL-10 -819 TT genotype is reversely associated with diffuse-subtype risk but not in intestinal-
subtype risk. IL-10 -819 TT genotype is not reversely associated with non-cardia or cardia subtype gastric cancer
susceptibility.
Conclusions: IL-10 -819 TT genotype seems to be more protective from gastric cancer in Asians. Whether IL-10
-819 TT genotype may be protective from gastric cancer susceptibility in persons infected with H. pylori or in
diffuse-subtype cancer needs further exploring in the future well-designed high quality studies among different
ethnicity populations. Direct sequencing should be more used in the future.
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Background
Nowadays, worldwide gastric cancer incidence has
decreased but its mortality still ranks second [1-3]. In
Asia [4], especially China [5], gastric cancer constitutes
the top lethal malignancy. As is widely known, infec-
tious, dietary, environmental, and genetic factors are
implicated in gastric carcinogenesis, but only a minority
of persons exposed to risk factors such as Helicobacter
pylori (H. pylori) infection ultimately develop gastric
cancer [6], which implies that host genetic susceptibility
plays an important role in developing gastric cancer
[7-9]. Such various susceptibilities could be explained, in
part, by single nucleotide polymorphisms (SNPs) of sus-
ceptible genes [7-9]. During the long pathogenesis from
chronic gastritis to gastric cancer spawned by H. pylori
infection, host-activated neutrophils and mononuclear
cells can produce not only proinflammatory cytokines
such as interleukin (IL)-1b, IL-6, IL-8 and tumor necro-
sis factor (TNF)-a but also anti-inflammatory cytokines
like IL-10. Rivetingly, the level of IL-10 besides those of
IL-1 and TNF-a c o u l da l s ob ee l e v a t e di ng a s t r i c
mucosa infected with H. pylori.
IL-10, a potent pleiotropic cytokine, has the dual abil-
ity to immunosuppress or immunostimulate anti-cancer
properties [10]. Interleukin-10 inhibits the production of
pro-inflammatory cytokines by inhibition of T-helper 1
(Th1) lymphocytes and stimulation of B lymphocytes
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inflammatory response [10-12]. The human IL-10 gene,
located on chromosome 1q31-32, consists of five exons
and four introns and one of polymorphisms is reported
in its promoter region at position -819 C/T SNP [13].
I n2 0 0 3 ,W uM Se ta l .[ 1 4 ]f i r s tp u b l i s h e dt h e i rs t u d y
on IL-10-819 C/T SNP. Since then, researchers have
consecutively reported associations of IL-10-819 C/T
SNP with the susceptibility to gastric cancer, but with
mixed or conflicting results [15-25]. Up to now, there
has been only one published meta-analysis article focus-
ing on IL-10-819 C/T SNP [26], but that meta-analysis
failed to adopt the most likely appropriate genetic
model, and thus the authentic values of statistical results
could be compromised.
Accordingly, the aim of our meta-analysis was to shed
more light, using the most appropriate genetic model,
on the role of IL-10-819 C/T SNP in the risk of devel-
oping gastric cancer and to identify possible sources of
heterogeneity among the eligible studies.
Methods
Search strategy
A systematic literature search was performed for articles
regarding IL-10-819 C/T SNP associated with the risk of
developing gastric cancer. The MEDLINE, EMBASE
databases, Chinese National Knowledge Infrastructure
(CNKI), Web of Science, and BIOSIS databases were
used simultaneously with the combination of terms
“Interleukin 10”, “IL-10”, “interleukin”,o r“cytokine";
“gene"; “polymorphism”, “variant”,o r“SNP"; and “gastric
cancer”, “gastric carcinoma”, “diffuse gastric cancer” or
“stomach cancer” from January 2000 to September 2011.
The search was performed without any restriction on
language. The scope of computerized literature search
was expanded according to the reference lists of
retrieved articles. The relevant original articles were also
sought manually.
Study selection
Studies concerning the association of IL-10-819 C/T
SNP with the risk of developing gastric cancer were
included if the following conditions were met: (i) any
study described the association of IL-10-819 C/T SNP
with gastric cancer; (ii) any study reported the numbers
of both controls and gastric cancer cases; (iii) results
were expressed as odds ratio (OR) with 95% confidence
intervals (CI); and (iv) studies were case-control or
nested case-control ones.
Methodological quality appraisal
To identify high-quality studies, we mainly adopted pre-
defined criteria for Quality Appraisal initially proposed
by Thakkinstian et al. [27], adapted by Camargo et al.
[28], and refined by Xue et al. [7-9]. The criteria (seen
in Additional file 1: Table S1) cover credibility of con-
trols, representativeness of cases, consolidation of gastric
cancer, genotyping examination, and association assess-
ment [7-9]. Methodological quality was independently
assessed by two investigators (B. Lin and J. An). Dis-
agreements were resolved through discussion. Scores
ranged from the lowest zero to the highest ten. Articles
with the score lower than 6.5 were considered “low or
moderate quality” ones, whereas those no lower than 6.5
were thought of as “high quality” ones.
Data extraction
The following data from each article were extracted:
authors, year of publication, country, ethnicity of partici-
pants (categorized as Caucasians, Asians, Latinos, etc.),
study design, source of controls, number of controls and
of cases, genotyping method, distribution of age and
gender, Lauren’s classification (intestinal, diffuse, or
mixed), and anatomical classification (cardia or non-car-
dia cancer).
The data were extracted and registered into two data-
bases independently by two investigators (B.Lin and J
An) who were blind to journal names, institutions or
fund grants. Any discrepancy between these two investi-
gators was resolved by the third investigator (H. Xue),
who participated in the discussion with them and made
an ultimate decision.
Statistical analysis
All statistical analyses were performed using STATA
statistical software (Version 10.1, STATA Corp, College
Station, TX). Two-sided Ps < 0.05 were considered sta-
tistically significant. HWE in controls was calculated
again in our meta-analysis. The chi-square goodness of
fit was used to test deviation from HWE (significant at
the 0.05 level). Odds ratios (OR) and 95% confidence
intervals (95% CI) were employed to assess the strength
of associations between IL-10-819 T/C SNP with gastric
cancer risk. OR1,O R 2,a n dO R 3 regarding IL-10-819 T/
C SNP were calculated for genotypes TT versus CC, CT
versus CC, and TT versus CT, respectively.
The above pairwise differences were used to determine
the most appropriate genetic model. If OR1 =O R 3 ≠ 1
and OR2 = 1, then a recessive model is suggested. If
OR1 =O R 2 ≠ 1a n dO R 3 = 1, then a dominant model is
implied. If OR2 =1 / O R 3 ≠ 1a n dO R 1 =1 ,t h e nac o m -
plete overdominant model is suggested. If OR1 >O R 2 >
1a n dO R 1 >O R 3 >1 ,o rO R 1 <O R 2 <1a n dO R 1 <
OR3 < 1, then a codominant model is indicated [29]. If
a dominant model was indicated, the original grouping
was collapsed and the new group of T carriers (TT +
CT) was compared with CC genotype; if a recessive
model was suggested, TT was compared to the group of
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Page 2 of 10CC plus CT; if a complete overdominant model was
implied, the group of TT plus CC was compared with
CT; or if a codominant model was insinuated, TT was
compared with CT and with CC, respectively.
The Q statistic was used to test for heterogeneity
among the studies included in the meta-analysis. A
fixed-effects model, using Mantel-Haenszel (M-H)
method, was used to calculate the pooled ORs when
h o m o g e n e i t ye x i s t e do nt h eb a s i so fQ - t e s tpv a l u en o
less than 0.1. By contrast, a random-effects model, using
DerSimonian and Laird method (D + L), was utilized if
there was heterogeneity based on Q-test p value less
than 0.1. The significance of pooled ORs was tested by
Z test (P < 0.05 was considered significant).
Sensitivity analysis was performed, in which the meta-
analysis estimates were computed after every one study
being omitted in each turn.
Finally, publication bias was assessed by performing
funnel plots qualitatively, and estimated by Begg’sa n d
Egger’s tests quantitatively.
Results
Literature search and study selection
After comprehensive searching, a total of 242 articles
(236 in English and 6 in Chinese) were retrieved. 230
articles were initially excluded after being read by their
respective title and abstract (203 not related gene poly-
morphism, 6 the same gene but not related locus poly-
morphisms, 7 related to other gastrointestinal diseases
other than gastric cancer, 2 related to precancerous gas-
tric lesions, 1 meta-analysis paper, 1 colorectal carci-
noma, 7 related to the effects of bacterial or viral factors
(2 Epstein-Barr virus, 5 Helicobacter pylori), 3 unrelated
reviews). In our meta-analysis were initially included
altogether 12 studies [14-25] which catered to the inclu-
sion criteria, and these 12 full-text articles then were
considered for further evaluation. 1 article was further
excluded due to its lacking normal healthy controls [25].
Those 11 studies seemed appropriate to the meta-analy-
sis of the associations with gastric cancer regarding IL-
10-819 T/C SNP. Two studies [20,24] were deviated
from HWE through our calculation. Generally speaking,
any study that deviated from Hardy-Weinberg equili-
brium should have been removed; however, considering
that the numbers of participants in those two studies
were large and given that sensitivity analyses would be
conducted, we remained those two studies in our meta-
analysis.
Thus, 11 studies [14-24] with a total of 4008 con-
trols and 1490 cases were ultimately eligible for the
meta-analysis of IL-10-819 T/C SNP. The correspond-
ing characteristics were seen in Table 1. The flow
chart of literature search and study selection was seen
in Figure 1.
Overall meta-analysis among different ethnicity
populations
OR1 (p value), OR2 (p value), and OR3 (p value) of IL-
10-819 T/C SNP for overall ethnicities were 0.87 (p =
0.202), 0.86 (p = 0.083), and 0.88 (p = 0.095), respec-
tively, hardly insinuating a probably suitable genetic
model effect of putative protective T allele. Meanwhile,
after ethnicity subgroup analysis, OR1 (p value), OR2 (p
value), and OR3 (p value) of IL-10-819 T/C SNP among
Asians were 0.81 (p = 0.120), 0.95 (p = 0.734), and 0.83
(p = 0.027), respectively, suggesting a recessive genetic
model effect of putative protective T allele (OR1 =O R 3
< 1 and OR2 = 1). Thus, the genotype TT was compared
with the combined genotype CT-plus-CC. As in Figure
2, for overall gastric cancer a statistically significant
finding could be noted among Asians (Figure 2A) but
not among Caucasians (Figure 2B) from the facts that
the pooled ORs (95% CI, p value) were 0.82 (0.70-0.96,
p = 0.015) for the former and 1.07 (0.50-2.26, p = 0.869)
for the latter. Only one included study [16] dealt with
latino population or mixed ethnicity, so pooled ORs
could not be calculated among latino population in our
meta-analysis.
Further subgroup analysis
Specific data for IL-10-819 T/C SNP were classified in
accordance with the quality appraisal scores, into high
quality (scores no less than 6.5) and median-and-low
quality (scores less than 6.5) subgroups among differ-
ent ethnicities. A statistically significant reverse asso-
ciation was only witnessed in Asians high quality
subgroup but not in Asians median-and-low quality
subgroup, on the grounds that the pooled ORs (95%
CIs, p value) were 0.71 (0.58-0.87, p = 0.001) for the
former and 1.05 (0.81-1.36, p = 0.719) for the latter.
The pooled ORs (95% CIs, p value) among Caucasians
median-and-low quality subgroup could not be calcu-
lated due to only 1 included study. The pooled ORs
(95% CIs, p value) among Caucasians high quality sub-
group were 0.71 (0.42-1.23, p = 0.225). If Asians high
quality subgroup and Caucasians high quality sub-
group were combined, and Asians median-and-low
quality subgroup, Caucasians median-and-low quality
subgroup, and Latinos median-and-low quality sub-
group were also combined, the pooled ORs (95% CIs,
p value) were 0.71 (0.59-0.86, p = 0.000) for the for-
mer (the combined high quality subgroup) and 1.15
(0.91-1.46, p = 0.240) for the latter (the combined
median-and-low quality subgroup), based on the
recessive genetic model in our initial option (Figure
3). To further confirm the recessive genetic model, the
above OR1 (p value), OR2 (p value), and OR3 (p value)
of IL-10-819 T/C SNP in the combined high quality
subgroup for overall ethnicities were 0.64 (p = 0.002),
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Page 3 of 10Table 1 Study Characteristics of genotypes in gastric cancer cases and controls in the analysis of Interleukin-10-819 Promoter Genetic Polymorphisms
First author Year of
publication
Quality assessment
scores
Genotyping
method
Total sample
size
Number of
controls
Number of
cases
Study
location
Ethnic
group
P values for
HWE
Controls,
genotypes(n)
All Cases,
genotypes(n)
CC CT TT CC CT TT
Wu MS 2003 7 Direct
sequencing
450 230 220 China Asians 0.231397685 20 83 127 27 105 88
Savage SA
# 2004 5 ABI Genetic
Analyzer
466 382 84 China Asians 0.314869012 49 163 170 9 38 37
Alpízar-
Alpízar W
2005 6 Pyrosequencing 90 45 45 Costa Rica Latinos 0.08326454 18 24 3 25 16 4
Zambon CF
^ 2005 5 TaqMan 773 644 129 Italy Caucasians 0.696436614 353 245 46 70 42 17
Kamangar
F
#^¶
2006 8 TaqMan 250 152 98 Finland Caucasians 0.66272429 80 62 10 58 35 5
Sugimoto
M
#^*¶+
2007 6.5 ASP 273 168 105 Japan Asians 0.194224595 9 73 86 6 57 42
Crusius JB
#^ 2008 8.5 ABI real-time
PCR
1323 1094 229 European Caucasians 0.02386503 636 378 80 145 72 12
Xiao H 2009 6 RFLP 844 624 220 China Asians 0.718880427 69 283 272 20 100 100
Ko KP 2009 7 SNaPshot 409 326 83 Korea Asians 0.038333741 37 121 168 11 33 39
Su SP 2010 6.5 RFLP 143 100 43 China Asians 0.433216715 6 43 51 4 21 18
Liu J
+ 2011 6.5 RFLP 477 243 234 China Asians 0.772829993 28 106 109 39 96 99
#Data of cardia-subtype gastric cancer were accessible; ^ Data of noncardia-subtype gastric cancer were accessible; * Data of sporadic diffuse-subtype gastric cancer were accessible; ¶ Data of intestinal-subtype
gastric cancer were accessible. +Data of the status of Helicobacter pylori of gastric cancer were accessible. RFLP: Restriction fragment length polymorphisms; TaqMan: 5’nuclease polymerase chain reaction assays;
Pyrosequencing: a method of DNA sequencing (determining the order of nucleotides in DNA) based on the “sequencing by synthesis” principle. It differs from Sanger sequencing, in that it relies on the detection of
pyrophosphate release on nucleotide incorporation, rather than chain termination with dideoxynucleotides; Direct sequencing: method of methylation analysis using bisulfite-treated DNA utilized PCR and standard
dideoxynucleotide DNA sequencing to directly determine the nucleotides resistant to bisulfite conversion; ASP: the allele specific primer-polymerase chain reaction (ASP-PCR) method; SNaPshot: the SNaPshot assay
which provides detection of certain SNPs
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00.82 (p = 0.065), and 0.75 (p = 0.004), respectively,
again indicating a recessive genetic model effect of
putative protective T allele (OR1 =O R 3 <1a n dO R 2
=1 ) .
When gastric cancer was classified into non-cardia (or
distal) and cardia subtypes, no statistically significant
findings were found among non-cardia subtype or
among cardia subtype on the grounds that the pooled
242Articles identified
236 in English
6 in Chinese
230Articles excluded (for title and abstract)
203 not related gene polymorphism
6 the same gene but not related locus 
polymorphisms
7 related to other gastrointestinal diseases 
other than gastric cancer
2 related to precancerous gastric lesions
1 meta-analysis paper
1 colorectal carcinoma
7 related to the effects of bacterial or viral 
factors (2 Epstein-Barr virus, 5 Helicobacter 
pylori)
3 unrelated reviews 
12Articles initially
considered for inclusion
0 Additional studies identified 
from retrieved articles
12 Full-text articles 
considered for further 
evaluation
11 studies included
8 in English
3 in Chinese 
1Article excluded
1 Lacking normal healthy 
controls
Figure 1 The flow chart of literature search and study selection.
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Page 5 of 10ORs (95% CIs, p value) were 0.82 (0.38-1.76, p = 0.603)
among non-cardia subtype and 1.02 (0.67-1.56, p =
0.913) among cardia subtype. In terms of pathology, gas-
tric cancer could be classified into intestinal, diffuse, or
mixed subtypes, and no statistically significant finding
was observed in intestinal-subtype cancer but in diffuse-
subtype cancer, for the pooled ORs (95% CIs, p value)
were 0.78 (0.48-1.27, p = 0.318) in the former and 0.32
(0.12-0.84, p = 0.021) in the latter.
In terms of H. pylori infection status, no statistically
significant reverse association was noted among either
H. pylori positive cancer patients compared with H.
pylori negative controls or among H. pylori positive can-
cer patients compared with H. pylori positive controls,
for pooled ORs (95% CIs, p value) were 0.64 (0.39-1.04,
p = 0.072) in the former and 0.90 (0.63-1.29, p = 0.575)
in the latter, but the p value was approximate to 0.05 in
the former.
And when genotyping techniques were considered, a
statistically significant finding was noted in direct
sequencing subgroup but not in any other genotyping
technique subgroup. In the direct sequencing, TaqMan,
ABI Genetic Analyzer, Pyrosequencing, Snapshot, RFLP,
ASP, and ABI real-time PCR genotyping technique sub-
groups, pooled ORs (95% CIs, p value) were 0.54 (0.37-
0.79, p = 0.001), 1.54 (0.91-2.60, p = 0.106), 0.98 (0.61-
1.58, p = 0.939), 1.37 (0.29-6.48, p = 0.695), 0.83 (0.51-
1.35, p = 0.460), 0.96 (0.77-1.21, p = 0.754), 0.64 (0.39-
1.04, p = 0.072), and 0.70 (0.38-1.31, p = 0.265),
respectively.
Sensitivity analysis
Meta-analyses were conducted repeatedly when each
particular study had been removed. The results indi-
cated that fixed-effects estimates and/or random-effects
estimates before and after the deletion of each study
were similar at large, suggesting moderate to high stabi-
lity of the meta-analysis results. The most influencing
single study on the overall pooled estimates seemed to
be the study conducted by Wu et al. [14], the sensitivity
analysis, however, indicated moderate stability of the
results from the facts that the ORs (95% CI, p value) for
all ethnicity were 0.86 (0.74-0.99, p = 0.037) before the
removal of that study and 0.94 (0.80-1.12, p = 0.488)
after the removal of that study. In view of the study [20]
conducted by Crusius JB et al. which is deviated from
HWE, the ORs (95% CI, p value) were 0.86 (0.74-0.99, p
= 0.037) before the removal of that study and 0.87
(0.75-1.01, p = 0.063) after the removal of that study for
the all ethnicity, indicating moderate to high stability of
the results. Similarly, after the removal of the study [24]
conducted by Ko KP et al., also deviated from HWE, the
OR (95% CI, p value) became 0.86 (0.74-1.00, p =
0.050), indicating high stability of the results (The illus-
trating figures were omitted due to the length of paper).
Cumulative meta-analysis
Cumulative meta-analyses of IL-10-819 T/C SNP asso-
ciation were also conducted among Asians (Figure 4A)
and among Caucasians (Figure 4B) via the assortment of
total number of sample size. As shown in Figure 4A, the
inclination toward significant reverse associations with
overall gastric cancer, though somewhat undulated, was
obviously seen among Asians, whereas in Figure 4B, the
seeming opposite tendency was observed among
Caucasians.
Publication bias analysis
Publication bias was preliminarily examined by funnel
plots qualitatively and estimated by Begg’s and Egger’s
tests quantitatively. Its funnel plot (Figure 5) showed that
dots nearly symmetrically distributed, predominantly
Figure 2 Odds ratios (ORs) for associations between IL-10-819
T/C SNP and gastric cancer risk (TT vs CT-plus-CC) among
different ethnicity populations, in order of increasing
publication year, 2003-2011. Studies were entered into the meta-
analysis sequentially by year of publication. The sizes of the squares
indicate the relative weight of each study. Bars, 95% confidence
interval (CI). A) among Asians; B) among Caucasians.
Figure 3 Odds ratios (ORs) for associations between IL-10-819
T/C SNP and gastric cancer risk (TT vs CT-plus-CC) among high
quality subgroup participants regardless of ethnicities and
among median-and-low quality subgroup participants
regardless of ethnicities. The sizes of the squares indicate the
relative weight of each study. Bars, 95% confidence interval (CI).
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Page 6 of 10Figure 4 Cumulative meta-analysis of associations between the IL-10-819 TT genotype, as compared with the combined CT-plus -CC
genotype, and gastric cancer risk among different ethnicity populations sorted by publication year and the total sample size.
Horizontal line, the accumulation of estimates as each study was added rather than the estimate of a single study. A) among Asians; B) among
Caucasians.
Figure 5 Funnel plot of publication bias for IL-10-819 SNP (TT vs CT-plus-CC). Note: Funnel plot with pseudo 95% confidence limits was
used.
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Page 7 of 10within pseudo 95% confidence limits. P values were 1.000
in Begg’s test and 0.897 in Egger’s test, separately, also
suggesting no publication bias.
Discussion
In our meta-analysis, a statistically significant finding
could be noted with the overall reduced risk of gastric
cancer among Asians but not among Caucasians (TT vs
CT-plus-CC); the opposite tendency toward the risk of
gastric cancer could also be observed between Cauca-
sians and Asians via cumulative meta-analysis sorted by
publication time and total sample size. Thus, IL-10-819
TT genotype may seem to be more protective from
overall gastric cancer susceptibility among Asians. To be
sure, the different or even conflicting risk associations, if
so, among different ethnicities should be further meticu-
lously investigated and confirmed in the future.
Our further subgroup analyses also indicate that a sta-
tistically significant reverse association was witnessed in
Asians high quality subgroup but not in Asians median-
and-low quality subgroup; the reverse association ten-
dency was also observed in Caucasians high quality sub-
group, although the statistical significance could not be
reached. The consistent reverse association trend
between Asians high quality subgroup and Caucasians
high quality subgroup could be apparently seen. The
strong statistical significant reverse association could be
found among the combined high quality subgroup
regardless of ethnicities based on the recessive genetic
model in our meta-analysis. Furthermore, the recessive
genetic model was confirmed through the recalculation
of OR1 (p value), OR2 (p value), and OR3 (p value) in
the combined high quality subgroup regardless of ethni-
cities. Therefore, it should be advocated that more rigor-
ous high-quality studies should be designed in the future
so as to accurately explore the real associations between
IL-10-819 TT genotype and gastric cancer susceptibility
among different ethnicities.
Additionally, 4[17-20] out of 11 eligible studies were
dealt with noncardia-subtype gastric cancer and 4
[15,18-20] with cardia-subtype gastric cancer. No statis-
tically significant findings could be noted with either
subtype (TT vs CT-plus-CC). 2 studies [18,19] in our
meta-analysis were dealt with pathologically intestinal-
subtype gastric cancer and only 1 [19] out of 11 studies
was dealt with pathologically diffuse-subtype gastric can-
cer. No statistically significant finding could be noted in
intestinal-subtype but in diffuse- subtype cancer (TT vs
CT-plus-CC). As is known, cardia-subtype gastric cancer
differs from noncardia-subtype gastric cancer in etiol-
ogy, pathology, carcinogenesis, and/or prognosis [30-32],
so is intestinal-subtype cancer versus diffuse-subtype
cancer. It could be said that the indiscriminate combina-
tion of cardia-subtype and noncardia-subtype cases or
intestinal-subtype and diffuse-subtype cases in the
majority of eligible studies may mask or at least under-
estimate the strength of the real associations [7-9].
Furthermore, it was reported that gastric cancer devel-
ops in those with H. pylori infection rather than in
uninfected ones [33]. In our meta-analysis, no statisti-
cally significant reverse association with gastric cancer
was found either among H. pylori positive cancer
patients compared with H. pylori negative controls or
among H. pylori positive cancer patients compared with
H. pylori positive controls (TT vs CT-plus-CC), but the
p value in the former was approximate to 0.05, insinuat-
ing that IL-10-819 TT genotype may seem to be more
protective from overall gastric cancer susceptibility in
persons infected with H. pylori. Certainly, the real asso-
ciation between Hp y l o r iinfection and IL-10-819 TT
genotype and gastric cancer susceptibility should be
further meticulously investigated in the future.
With the coming of new genotyping technologies like
seminested polymerase chain reaction, TaqMan allelic
discrimination test, direct sequencing, the allele specific
primer-polymerase chain reaction, pyrosequencing, or
r e a l - t i m eP C R ,w em a yw i t n e s sa nu p s u r g eo fg e n e t i c
association studies in the future. In our meta-analysis,
a statistically significant reverse association with gastric
cancer susceptibility was only noted in direct sequen-
cing technique subgroup but not in any other genotyp-
ing subgroup. The fact that the most significant result
can be witnessed in direct sequencing technology in
our meta-analysis is not necessarily a valid reason to
demonstrate that other technologies cannot be used.
Certainly, for a novel genotyping technique to be
employed for the study of a particular genetic poly-
morphism, this technology should better be confirmed
using direct sequencing. In that case, this new technol-
ogy can be seen as valid as direct sequencing. Or the
sensitivity and specificity of those genotyping techni-
ques need to be explored so as to seek out optimal
approaches which could minimize the genotyping
errors [7-9]. Our opinion is that direct sequencing
should be more used in future well-designed studies
among different ethnicity populations.
And the mechanism of the influence of IL-10-819 SNP
on carcinogenesis is still unknown, but it has been
reported that IL-10 SNPs may influence immune func-
tion through modulating the activities of the NK cell, T
cells, and macrophages and thus alter the disease pro-
gression [34]. Additionally, another investigated SNP at
position -1082 (A/G) was reported to be significantly
increased in prostate cancer patients and its action,
together with VEGF and IL-8, was suspected to possibly
influence cancer angiogenesis [35]. Whether IL-10-819
SNP may also influence cancer angiogenesis is worthy of
further investigating in the future.
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Page 8 of 10Finally, the strength of our meta-analysis could be
summarized as follows. We sought to find as many pub-
lications as we could by means of various searching
approaches. Any study that appeared to deviate from
HWE was not excluded mechanically in our meta-analy-
sis unless there are other convincing grounds for doubt-
ing the quality of the study [36]. We laid more emphasis
on assessing biases across studies and pinpointing the
potential sources of heterogeneity via subgroup and sen-
sitivity analyses. More importantly, we have made great
efforts to stratify ethnicity into Asians subgroup and
Caucasian subgroup in accordance with accessible data.
In particular, we have conducted overall meta-analysis
among different ethnicity populations to carefully
choose the most likely appropriate genetic model. We
also have stratified the included studies through other
subgroup analyses like anatomic classification, pathologi-
cally Lauren’s classification, H. pylori infection status,
sample size, and quality appraisal scores. We compre-
hensively assessed the publication biases using several
means like Begg’s and Egger’s tests as well as funnel
plot tests. In view of this, we convince that the results
of our meta-analysis, in essence, are sound and reliable.
Certainly, there are some unavoidable limitations in
our meta-analysis. Firstly, the information about overall
gastric cancer susceptibility is predominantly provided,
while other information about pathologic subtypes or
anatomic subtypes of gastric cancer is less provided.
Thus, the specific subtype results should be considered
with caution. Secondly, with the merely published stu-
dies included in our meta-analysis, publication bias is
very likely to occur, though no statistically significant
publication bias is found in our meta-analysis. Thirdly,
slight to moderate heterogeneity could be witnessed
among the included studies. So as to minimize the
potential bias, we designed a rigorous protocol before
conducting our meta-analysis, and performed a scrupu-
lous search for published studies using explicit methods
for study selection, data extraction, statistical analysis,
adoption of the most appropriate genetic model with
extreme caution and sensitivity analysis.
Conclusions
In conclusion, IL-10-819 TT genotype may seem to be
more protective from overall gastric cancer susceptibility
among Asians and even more protective in high quality
subgroup Asians. IL-10-819 TT genotype is not statisti-
cally associated with gastric cancer susceptibility in per-
sons infected with H. pylori. IL-10-819 TT genotype is
not associated with pathologic intestinal subtype but in
diffuse subtype and not with anatomic subtypes (non-
cardia or cardia) of gastric cancer susceptibility in our
meta-analysis. Direct sequencing should be more used
in future well-designed high quality studies among dif-
ferent ethnicities or populations.
Additional material
Additional file 1: Table S1. Scales for Quality Assessment.
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